Pathological role of hypoxia in Alzheimer's disease

Experimental Neurology

Volumn 223, Issue 2, 2010, Pages 299-303

  Zhang, Xin ^a   Le, Weidong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Blood brain barrier; Hypoxia; Neuron degeneration; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; TAU PROTEIN;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN HYPOXIA; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMAN; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; HUMANS; HYPOXIA, BRAIN;

EID: 77952549255     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.07.033     Document Type: Review

References (61)

1. Adams S., Green P., Claxton R., Simcox S., Williams M.V., Walsh K., Leeuwenburgh C. Reactive carbonyl formation by oxidative and non-oxidative pathways. Front. Biosci. 2001, 6:17-24.
2. Adhami F., Liao G., Morozov Y.M., Schloemer A., Schmithorst V.J., Lorenz J.N., Dunn R.S., Vorhees C.V., Wills-Karp M., Degen J.L., Davis R.J., Mizushima N., Rakic P., Dardzinski B.J., Holland S.K., Sharp F.R., Kuan C.Y. Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am. J. Pathol. 2006, 169:566-583.
3. Alonso A.C., Li B., Grundke-Iqbal I., Iqbal K. Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr. Alzheimer Res. 2008, 5:375-384.
4. Altieri M., Di P.V., Pasquini M., Gasparini M., Vanacore N., Vicenzini E., Lenzi G.L. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004, 62:2193-2197.
5. 2+ exchanger expression in cortical astrocytes. Neuroreport 2006, 17:649-652.
6. Bell R.D., Deane R., Chow N., Long X., Sagare A., Singh I., Streb J.W., Guo H., Rubio A., Van Nostrand W., Miano J.M., Zlokovic B.V. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat. Cell. Biol. 2009, 11:143-153.
7. Carbonell T., Rama R. Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr. Med. Chem. 2007, 14:857-874.
8. Chen G.J., Xu J., Lahousse S.A., Caggiano N.L., de M.S. Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J. Alzheimers Dis. 2003, 5:209-228.
9. Chow N., Bell R.D., Deane R., Streb J.W., Chen J., Brooks A., Van Nostrand W., Miano J.M., Zlokovic B.V. Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:823-828.
10. De S.B. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-secretase complex. Neuron 2003, 38:9-12.
11. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med. 2003, 9:907-913.
12. Deane R., Sagare A., Hamm K., Parisi M., Lane S., Finn M.B., Holtzman D.M., Zlokovic B.V. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest. 2008, 118:4002-4013.
13. Dominguez D.I., Hartmann D., De S.B. BACE1 and presenilin: two unusual aspartyl proteases involved in Alzheimer's disease. Neurodegener. Dis. 2004, 1:168-174.
14. El Khoury J., Hickman S.E., Thomas C.A., Loike J.D., Silverstein S.C. Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol. Aging 1998, 19:S81-84.
15. Farkas E., Donka G., de Vos R.A., Mihaly A., Bari F., Luiten P.G. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol. 2004, 108:57-64.
16. Fisk L., Nalivaeva N.N., Boyle J.P., Peers C.S., Turner A.J. Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem. Res. 2007, 32:1741-1748.
17. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
18. Hickman S.E., Allison E.K., El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 2008, 28:8354-8360.
19. Honig L.S., Kukull W., Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 2005, 64:494-500.
20. Kalaria R.N., Bhatti S.U., Palatinsky E.A., Pennington D.H., Shelton E.R., Chan H.W., Perry G., Lust W.D. Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport 1993, 4:211-214.
21. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 2002, 3:862-872.
22. Lee D.H., O'Commor T.R., Pfeifer G.P. Oxidative DNA damage induced by copper and hydrogen peroxide promotes CG->TT tandem mutations at methylated CpG dinucleotides in nucleotide excision repair-deficient cells. Nucleic Acids Res. 2002, 30:3566-3573.
23. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., Selkoe D.J. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003, 40:1087-1093.
24. Li L., Zhang X., Yang D., Luo G., Chen S., Le W. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP. Neurobiol. Aging 2009, 30:1091-1098.
25. Mackic J.B., Bading J., Ghiso J., Walker L., Wisniewski T., Frangione B., Zlokovic B.V. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vascul. Pharmacol. 2002, 38:303-313.
26. Malito E., Hulse R.E., Tang W.J. Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin. Cell. Mol. Life Sci. 2008, 65:2574-2585.
27. Michaelis M.L., Dobrowsky R.T., Li G. Tau neurofibrillary pathology and microtubule stability. J. Mol. Neurosci. 2002, 19:289-293.
28. Monro O.R., Mackic J.B., Yamada S., Segal M.B., Ghiso J., Maurer C., Calero M., Frangione B., Zlokovic B.V. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging 2002, 23:405-412.
29. Mukherjee P.K., Marcheselli V.L., Serhan C.N., Bazan N.G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8491-8496.
30. Nalivaevaa N.N., Fisk L., Kochkina E.G., Plesneva S.A., Zhuravin I.A., Babusikova E., Dobrota D., Turner A.J. Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann. N.Y. Acad. Sci. 2004, 1035:21-33.
31. Oddo S., Caccamo A., Tseng B., Cheng D., Vasilevko V., Cribbs D.H., LaFerla F.M. Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology. J. Neurosci. 2008, 28:12163-12175.
32. Pichiule P., Chavez J.C., Schmidt A.M., Vannucci S.J. Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. J. Biol. Chem. 2007, 282:36330-36340.
33. Plattner F., Angelo M., Giese K.P. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J. Biol. Chem. 2006, 281:25457-25465.
34. Pluta R. Pathological opening of the blood-brain barrier to horseradish peroxidase and amyloid precursor protein following ischemia-reperfusion brain injury. Chemotherapy 2005, 51:223-226.
35. Pluta R., Barcikowska M., Mossakowski M.J., Zelman I. Cerebral accumulation of beta-amyloid following ischemic brain injury with long-term survival. Acta Neurochir. Suppl. 1998, 71:206-208.
36. Reynolds P.R., Mucenski M.L., Le Cras T.D., Nichols W.C., Whitsett J.A. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J. Biol. Chem. 2004, 279:37124-37132.
37. Saragoni L., Hernandez P., Maccioni R.B. Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells. Neurochem. Res. 2000, 25:59-70.
38. Schneider J.A., Wilson R.S., Cochran E.J., Bienias J.L., Arnold S.E., Evans D.A., Bennett D.A. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003, 60:1082-1088.
39. Selim M.H., Ratan R.R. The role of iron neurotoxicity in ischemic stroke. Ageing Res. Rev. 2004, 3:345-353.
40. Selwood S.P., Parvathy S., Cordell B., Ryan H.S., Oshidari F., Vincent V., Yesavage J., Lazzeroni L.C., Murphy G.M. Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E. Neurobiol. Aging 2009, 30:574-590.
41. Siesjo B.K. A new perspective on ischemic brain damage?. Prog. Brain Res. 1993, 96:1-9.
42. Siu A.W., To C.H. Nitric oxide and hydroxyl radical-induced retinal lipid peroxidation in vitro. Clin. Exp. Optom. 2002, 85:378-382.
43. Spencer B., Marr R.A., Rockenstein E., Crews L., Adame A., Potkar R., Patrick C., Gage F.H., Verma I.M., Masliah E. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. BMC Neurosci. 2008, 9:109.
44. Stephenson D.T., Rash K., Clemens J.A. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 1992, 593:128-135.
45. Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L.E., Song W. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18727-18732.
46. Swerdlow R.H. Pathogenesis of Alzheimer's disease. Clin. Interv. Aging 2007, 2:347-359.
47. Ueno M., Tomimoto H., Akiguchi I., Wakita H., Sakamoto H. Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J. Cereb. Blood Flow Metab. 2002, 22:97-104.
48. Urmoneit B., Prikulis I., Wihl G., D'Urso D., Frank R., Heeren J., Beisiegel U., Prior R. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 1997, 77:157-166.
49. Wang R., Zhang Y.W., Zhang X., Liu R., Zhang X., Hong S., Xia K., Xia J., Zhang Z., Xu H. Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J. 2006, 20:1275-1277.
50. Waypa G.B., Schumacker P.T. Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J. Appl. Physiol. 2005, 98:404-414.
51. Wen Y., Yang S., Liu R., Brun-Zinkernagel A.M., Koulen P., Simpkins J.W. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J. Biol. Chem. 2004, 279:22684-22692.
52. Xie H., Ray P.E., Short B.L. NF-kappaB activation plays a role in superoxide-mediated cerebral endothelial dysfunction after hypoxia/reoxygenation. Stroke 2005, 36:1047-1052.
53. Yamamoto T., Maruyama W., Kato Y., Yi H., Shamoto-Nagai M., Tanaka M., Sato Y., Naoi M. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J. Neural. Transm. 2002, 109:1-13.
54. Yamamoto M., Kiyota T., Horiba M., Buescher J.L., Walsh S.M., Gendelman H.E., Ikezu T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 2007, 170:680-692.
55. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
56. Yan F.L., Zheng Y., Zhao F.D. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Acta Neuropathol. 2008, 116:529-535.
57. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O., Jiang Y., Duff K., Uchiyama Y., Naslund J., Mathews P.M., Cataldo A.M., Nixon R.A. Macroautophagy-a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell. Biol. 2005, 171:87-98.
58. Zerbinatti C.V., Wahrle S.E., Kim H., Cam J.A., Bales K., Paul S.M., Holtzman D.M., Bu G. Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice. J. Biol. Chem. 2006, 281:36180-36186.
59. Zhang X., Zhou K., Wang R., Cui J., Lipton S.A., Liao F.F., Xu H., Zhang Y.W. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 2007, 282:10873-10880.
60. Zhou W., Scott S.A., Shelton S.B., Crutcher K.A. Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease. Neuroscience 2006, 143:689-701.
61. Zlokovic B.V., Yamada S., Holtzman D., Ghiso J., Frangione B. Clearance of amyloid beta-peptide from brain: transport or metabolism?. Nat. Med. 2000, 6:718.